New drug 'showing positive results in more than third of high-risk leukemia patients'

A new drug for patients with acute myeloid leukemia , marked by a specific type of genetic mutation, has shown surprising promise in a Phase II clinical trial.

http://www.newkerala.com/news/newsplus/worldnews-115231.html